Business Segments

9 Months Ended

Sep. 29, 2018

Segment Reporting [Abstract]

Business Segments

10. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by geographic region, based on the sales destination, is as follows:

	Three Months Ended				Nine Months Ended
(in thousands)	September 29, 2018		September 30, 2017		September 29, 2018		September 30, 2017
United States	$	6,182	$	6,294	$	16,156	$	17,880
Europe		2,020		1,727		6,680		5,502
Rest of Americas		554		689		1,862		1,853
Asia/Pacific Rim		2,564		2,155		6,435		6,115
	$	11,320	$	10,865	$	31,133	$	31,350

Revenues are attributed to countries based on location of end customers.

Other than the United States, China accounted for more than 10% of the Company’s revenues during the three months ended September 29, 2018, representing 11%. No individual country accounted for more than 10% of the Company’s revenues, other than the United States, during the nine months ended September 29, 2018 and during the three and nine months ended September 30, 2017. The United States accounted for 54.6% and 57.9% of revenues for the three months ended September 29, 2018 and September 30, 2017, respectively. For the nine months ended September 29, 2018 and September 30, 2017, the United States accounted for 51.9% and 57.0% of sales, respectively. International sales accounted for 45.4% and 42.1% of revenues for the three months ended September 29, 2018 and September 30, 2017, respectively. For the nine months ended September 29, 2018 and September 30, 2017, International sales accounted for 48.1% and 43.0% of sales, respectively.